NCT07505875Recruiting
Pre-implementation Study to Develop Trans-tailored Services for Transgender Persons in Relation to chemsEX
Source: ClinicalTrials.gov · Last updated 6 Apr 2026
Brief summary (registry, in English)
The study is a pre-implementation cross-sectional study exploring chemsex behaviors among transgender persons and gathering perspectives from multiple stakeholders to inform the development of transgender-tailored harm reduction services.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 22 Mar 2026
- Start date
- 1 May 2024
- Primary completion date
- 1 Dec 2026
- Lead sponsor
- Institute of HIV Research and Innovation Foundation, Thailand
- Diseases
- HIV
- NCT number
- NCT07505875
What you commit to
- Study type: Observational
- Planned participants: 50
- From 1 May 2024 to the primary completion date, 1 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Unable to participate in in-depth interview (IDI) (online or onsite)
Who the study is looking for
- Age ≥18 years
- Able to communicate in Thai
- Provide informed consent
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tangerine Clinic, Institute of HIV Research and Innovation Coordinator of this site? Confirm its status | Pathum Wan | Thailand | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.